Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

FSD Pharma Inc C.HUGE

Alternate Symbol(s):  HUGE

Healthcare Cannabis
FSD Pharma Inc. is a Canada-based biotechnology company. The Company operates through two segments: Biotechnology and Strategic Investments. Its Biotechnology segment is focused on furthering the research and development of the Company’s two primary drug candidates consisting of Lucid-MS and Lucid-PSYCH, as well as the development of UNBUZZD. The Company’s Strategic Investments segment is focused on generating returns and cashflow through the issuance of loans secured by residential or commercial real estate property. Lucid-PSYCH is a molecular compound identified for the potential treatment of mental health disorders. Lucid-MS is a molecular compound identified for the potential treatment of neurodegenerative disorders. UNBUZZD is a proprietary formulation of natural ingredients, vitamins, and minerals to help with liver and brain function for the purposes of potentially quickly relieving from the effects of alcohol consumption, such as inebriation, and restoring normal lifestyle.


CSE:HUGE - Post by User

FSD Pharma Inc
Bullboard Posts
User Avatar Image
(2)
•••
Comment by Crazydavidon Sep 02, 2019 10:00am
147 Views
Post# 30087987

RE:RE:RE:RE:RE:A post from Curris

RE:RE:RE:RE:RE:A post from Curris
Stetsen wrote: I think that this is the building model they are going to follow. Building out 30,000 square feet at a time and using only revenue from sales, so that they can remain debt free. Just my opinion.

I quite agree with you Stetsen, they are doing it the correct way. Gradually building without getting into debt. They will also know how much buildout they require rather than borrow money to build nearly 4 million sq. ft. all at once and then find out they didn't need all that space because we don't know how much the market there is for this product with so many others in this field. I give them full credit being cautious and looking after the interest of the shareholders. Have patience which is the key. This is going to be a "Rags to Riches" story. I am down but not out. I strongly believe in this company and one day maybe one year or maybe five years we will be rewarded. Just be strong and don't believe the naysayers.
Bullboard Posts
Dealroom for high-potential pre-IPO opportunities